在mRNACOVID-19疫苗接种后探索的潜在机制:一种极其罕见的副作用
Ahmed Faisal Mutee1, Abdulkareem Shareef2, S Renuka Jyothi3
1College of Pharmacy, Alnoor University, Mosul, Iraq.
Scandinavian journal of immunology
|October 21, 2025
概括
对于大多数患者 (PWE) 来说,mRNA COVID-19 疫苗是安全的,罕见的发作恶化. 研究探讨神经免疫链接,以了解风险,并提高疫苗安全性,为弱势群体.
科学领域:
- 神经免疫学 神经免疫学
- 疫苗学 疫苗学 疫苗学
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- mRNA COVID-19 疫苗 (Pfizer-BioNTech,Moderna) 在一般人群中显示出高效率和安全性.
- 人们对患者的神经系统不良影响 (PWE) 存在担忧.
- 现有的临床数据表明,大多数PWE都能很好地耐受疫苗接种,暂时性发作恶化率约为5%.
研究的目的:
- 审查神经免疫机制,可能将mRNA疫苗接种与PWE中的发作恶化联系起来.
- 评估mRNA疫苗在患者中的安全性和有效性.
- 识别知识上的差距,并提出未来的研究方向.
主要方法:
- 来自病例报告,多中心研究和元分析 (超过3000个PWE) 的临床数据的审查.
- 检查潜在的神经免疫通路,包括免疫激活,神经炎症和发.
- 对与mRNA疫苗平台相关的神经副作用的分析.
主要成果:
- 大多数PWE都能很好地耐受mRNA疫苗接种;发作恶化通常是短暂的,比COVID-19后感染更少.
- 罕见的严重事件,如状态发作发生,但背景发作发病率仍然可比或低于自然率.
- 神经系统的副作用,如贝尔和横侧髓炎,在mRNA平台中更为普遍,可能是由于LNP诱导的炎症.
结论:
- mRNA疫苗的益处可能超过PWE的风险,但个体倾向性需要进一步研究.
- 了解神经免疫触发因素 (细胞因子风暴,BBB破坏,分子模拟) 对于疫苗安全至关重要.
- 未来的研究应该专注于纵向研究,EEG监测,AI,多omics和计算建模,以进行个性化风险评估和药物监测.
更多相关视频
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
814
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
814
Antiepileptic Drugs: Potassium Channel Activators
631
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
631
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Local Anesthetics: Adverse Effects
751
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
751


